Fundz

Sk Inc., The Second Largest Conglomerate In South Korea, Has Invested $350 Million In The Center For Breakthrough Medicines

PRIVATEJan 10, 2022

Amount Raised

$350 Million

Round Type

Funding Round

ManufacturingHealth Care

Description

The Center for Breakthrough Medicines (CBM) announced today that it has received $350 million in equity financing from SK Inc. (KRX: 034730) (SK). CBM is partnering with SK to create the world's largest end-to-end cell and gene therapy contract development and manufacturing organization (CDMO).

Quick answer

The Center For Breakthrough Medicines raised $350 Million in a Funding Round round, dated January 10, 2022.

How much did The Center For Breakthrough Medicines raise?
The Center For Breakthrough Medicines raised $350 Million in a Funding Round round on January 10, 2022.
What does The Center For Breakthrough Medicines do?
CBM is a horizontally integrated cell and gene therapy contract development and manufacturing organization (CDMO).

Source: Fundz verified event record.

Who else raised in Manufacturing and Health Care around the same time

Companies in the same sectors as The Center For Breakthrough Medicines that raised within 45 days of this round, from Fundz verified event records.

  • Confluent Medical raised an undisclosed amount on February 17, 2022.
  • Electra Therapeutics raised $84M (Series B) on February 16, 2022.
  • Armis Biopharma raised $7.3M on February 15, 2022.
  • Levita Magnetics International Corp. raised $20M on February 15, 2022.
  • Enable Injections raised $150M on February 3, 2022.
  • Third Pole raised $25M (Funding Round) on February 3, 2022.

Who to call at The Center For Breakthrough Medicines, and when

A new round usually means The Center For Breakthrough Medicines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day The Center For Breakthrough Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at The Center For Breakthrough Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at The Center For Breakthrough Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

The Center For Breakthrough Medicines

About

CBM is a horizontally integrated cell and gene therapy contract development and manufacturing organization (CDMO). CBM offers fully integrated, bench to bedside, pre-clinical through commercial manufacturing capabilities including, process development, plasmid DNA, viral vector manufacturing, cell banking, cell processing, and a full suite of complimentary testing and analytic capabilities. CBM's innovative horizontal integration enables the utmost quality and accelerates time to market and affordability of advanced therapies from discovery to commercialization without compromising quality through a single-source, end-to-end solution, providing the opportunity for incubators, academics, researchers, and companies small to large to align with the most comprehensive manufacturing partner in the industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment The Center For Breakthrough Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for The Center For Breakthrough Medicines's next move

See what Strategic adds

The Center For Breakthrough Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.